- Home
- TEO vs CNTA Comparison
TEO vs CNTA Comparison
Compare TEO & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TEO
- CNTA
- Stock Information
- Founded
- TEO 1979
- CNTA 2020
- Country
- TEO Argentina
- CNTA United Kingdom
- Employees
- TEO N/A
- CNTA N/A
- Industry
- TEO Telecommunications Equipment
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- TEO Telecommunications
- CNTA Health Care
- Exchange
- TEO Nasdaq
- CNTA Nasdaq
- Market Cap
- TEO 2.7B
- CNTA 2.2B
- IPO Year
- TEO N/A
- CNTA 2021
- Fundamental
- Price
- TEO $13.20
- CNTA $16.00
- Analyst Decision
- TEO Sell
- CNTA Strong Buy
- Analyst Count
- TEO 1
- CNTA 7
- Target Price
- TEO $6.10
- CNTA $23.71
- AVG Volume (30 Days)
- TEO 252.1K
- CNTA 463.7K
- Earning Date
- TEO 11-26-2024
- CNTA 11-12-2024
- Dividend Yield
- TEO N/A
- CNTA N/A
- EPS Growth
- TEO N/A
- CNTA N/A
- EPS
- TEO 0.21
- CNTA N/A
- Revenue
- TEO $1,780,106,477.00
- CNTA $6,853,000.00
- Revenue This Year
- TEO $91.50
- CNTA N/A
- Revenue Next Year
- TEO $39.96
- CNTA N/A
- P/E Ratio
- TEO $14.10
- CNTA N/A
- Revenue Growth
- TEO N/A
- CNTA N/A
- 52 Week Low
- TEO $5.06
- CNTA $5.58
- 52 Week High
- TEO $13.53
- CNTA $18.74
- Technical
- Relative Strength Index (RSI)
- TEO 80.49
- CNTA 49.07
- Support Level
- TEO $10.67
- CNTA $15.15
- Resistance Level
- TEO $12.06
- CNTA $18.74
- Average True Range (ATR)
- TEO 0.79
- CNTA 0.88
- MACD
- TEO 0.31
- CNTA 0.10
- Stochastic Oscillator
- TEO 93.50
- CNTA 35.68
About TEO Telecom Argentina SA
Telecom Argentina SA offers its customers quadruple play services, combining mobile telephony services, cable television services, Internet services and fixed telephony services. It also provides other telephone-related services such as international long-distance and wholesale services, data transmission and IT solutions outsourcing and install, operate and develop cable television and data transmission services. The company provides services in Argentina (mobile, cable television, Internet and fixed and data services), Paraguay (mobile, Internet and satellite TV services), Uruguay (cable television services) and the United States (fixed wholesale services).
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.